This HTML5 document contains 127 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1586/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q53665050
rdf:type
wikibase:Item
schema:description
2014年学术文章 2014年学术文章 teaduslik artikkel artikel ilmiah artikull shkencor videnskabelig artikel article scientifique artykuł naukowy מאמר מדעי artigo científico tieteellinen artikkeli articol științific 2014年學術文章 artículu científicu 2014年の論文 vědecký článek scientific article published on 13 December 2014 2014年學術文章 bilimsel makale vedecký článok 2014年学术文章 scienca artikolo مقالة علمية نشرت في 13 ديسمبر 2014 artigo científico tudományos cikk naučni članak სამეცნიერო სტატია мақолаи илмӣ vitenskapelig artikkel 2014年學術文章 vetenskaplig artikel 2014 nî lūn-bûn scientific article published on 13 December 2014 научни чланак научная статья 2014年学术文章 2014年學術文章 บทความทางวิทยาศาสตร์ wetenschappelijk artikel επιστημονικό άρθρο наукова стаття, опублікована в грудні 2014 artikulong pang-agham article scientific artículo científico publicado en 2014 articolo scientifico 2014年学术文章 ১৩ ডিসেম্বর ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artigo científico article científic vitskapeleg artikkel 2014年学术文章 научни чланак bài báo khoa học wissenschaftlicher Artikel 2014年學術文章 scientific article published on 13 December 2014 2014년 논문 научна статия
p:P577
wds:Q53665050-86EAF1B0-9DEE-4CE5-9777-4BB524E45D35
wdt:P577
2014-12-13T00:00:00Z
p:P2860
wds:Q53665050-A7C609CD-0F81-4BFC-970C-9FB0B09C91B1 wds:Q53665050-B6551904-5FF7-4388-A9D4-8D672D0EB8E5 wds:Q53665050-B9ACDC6F-0416-47E8-A848-FD6A3927D46C wds:Q53665050-BC269BBD-C23C-4EDE-B593-E3E504660F29 wds:Q53665050-88FF6B21-1C6A-4565-A782-A21152D05F34 wds:Q53665050-9346F75A-8F4E-477B-A709-EBB543507955 wds:Q53665050-DEAC3170-312D-4111-93EC-D39DB27F7FD9 wds:Q53665050-EF02F11F-72E7-4BF6-A17F-BD981555DD11 wds:Q53665050-348F18FF-05DD-4A5B-806F-689EB40C33B2 wds:Q53665050-3E6E8DBD-7BE5-4BAD-B6CC-06DDC9DD81AB wds:Q53665050-60B59706-BF27-4FB3-BDBE-2450A8C551E9 wds:Q53665050-435F67EF-3984-4CC9-85DC-D3BC25C9415D wds:Q53665050-4EE69C58-E4A4-4E5B-85A4-E4BB59CC1306
wdt:P2860
wd:Q45814844 wd:Q46859754 wd:Q34976967 wd:Q52896069 wd:Q38489593 wd:Q36834360 wd:Q37799354 wd:Q44078727 wd:Q42523410 wd:Q34378153 wd:Q42489030 wd:Q57244488 wd:Q35047662
p:P2093
wds:Q53665050-DCEE4107-EAD7-4CB2-B929-816ED2B49AE3 wds:Q53665050-D100E6C1-2E9B-4B87-9839-9A6F1E192DEE wds:Q53665050-E725C4E7-498E-4D36-963A-170C1F1A4F3B wds:Q53665050-F37CD262-227C-4213-9F87-EEF2043DB9FD wds:Q53665050-16725F90-B996-49C0-8472-43CCDD019CA3
wdt:P2093
Ruth Puig-Peiró Max Brosa Carlos Ferrándiz Diana Nieves Maria Josep Plazas
rdfs:label
Cost-effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain. Cost-effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain.
skos:prefLabel
Cost-effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain. Cost-effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain.
schema:name
Cost-effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain. Cost-effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain.
p:P1476
wds:Q53665050-D8E8C982-E850-459C-A628-7F589E15FCEF
wdt:P1476
Cost-effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain.
p:P304
wds:Q53665050-3477F9B2-6156-42EB-9DC9-F92787CDA83C
wdt:P304
539-543
p:P31
wds:Q53665050-4145CA65-6A58-40AF-BF02-197F536975C2
wdt:P31
wd:Q13442814
p:P921
wds:Q53665050-D84A2F98-C61D-4FFF-9038-30A5C1410884 wds:Q53665050-5BE2CC7E-0155-4B76-81A1-8D4BAB38BEB4 wds:Q53665050-8271FD95-8DEF-49D3-99AF-3B2BB52E8C3F
wdt:P921
wd:Q238512 wd:Q3667186 wd:Q422225
p:P698
wds:Q53665050-6AEE2A8E-0A86-4FE2-A337-BA46F1E69877
wdtn:P698
n11:25495775
wdt:P698
25495775
p:P1433
wds:Q53665050-A168E8AD-8349-4B4F-B1C0-C7E90B231D17
wdt:P1433
wd:Q15734522
p:P433
wds:Q53665050-DD24BA7D-5B46-450A-A1E6-C1D0A69F8017
p:P478
wds:Q53665050-6E6B0B9D-0A90-428C-83B5-B264DA766592
wdt:P433
3
wdt:P478
15
p:P356
wds:Q53665050-F3B40490-E370-4C1B-8929-1F14FA916947
wdtn:P356
n12:14737167.2015.995171
wdt:P356
10.1586/14737167.2015.995171